Insider buying last 90 days
No open-market insider purchases were filed for RXO in the last 90 days.
From Form 4 filings, dated to when each was filed.
This week's move centers on the announced acquisition of RXO by C.H. Robinson Worldwide in a stock-and-cash transaction with an implied value of $5.8 billion, creating a combined company with an enterprise value exceeding $25 billion. RXO will continue to operate independently with its current customer teams, operations and systems until the deal closes. Separately, class action firms including Monteverde & Associates and Kahn Swick & Foti have announced investigations into the adequacy of the price and process of the proposed sale, while at least one piece noted RXO's momentum alongside a reasonable valuation screen.
RXO closed at $28.69, down 1.3% on the day, with the stock sitting above both its 50-day average of $21.93 and 200-day average of $20.01, and the 50-day above the 200-day. The GekkoIndex reads 37.9, placing RXO in the Distribution zone. Price sits 20.2% above the Gekko Fair Value of $23.87.
RXO's next earnings date falls on 5 November 2026, before the open, 24 days away and inside a typical 20-trading-day holding window; the prior quarter saw a beat of $0.06 versus a $0.04 estimate with a 3.3% reaction. No insider, Congress or unusual options activity appears in the respective windows. Seasonality over the next 20 trading days has averaged -6% across 3 years, rising in 1 of them. Analyst consensus stands at 4 buy and 10 hold ratings among 14 firms, with a consensus target of $27.04.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
RXO scores 1 supportive, 0 mixed and 4 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive0 mixed4 headwinds
Above 50 and 200-day
Close $28.69 is above the 50-day ($21.93) and 200-day ($20.01) averages, and the 50-day is above the 200-day.
See the chart37.9, Distribution
Reading 37.9 is in the Distribution zone.
See the GekkoIndex20.2% above
Price is 20.2% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 24 days
Reports on Nov 5, 2026, 24 days away — inside a typical 20-trading-day hold.
See earnings−6.0% on average
From this point in the calendar, the next 20 trading days averaged −6% over 3 years, rising in 1 of them.
See seasonalityA description of current data, not a recommendation. How this page works
RXO closed at $28.69 on Oct 12, 2026, +62.5% over the past year, inside a 52-week range of $10.43 to $29.90.
Use the left and right arrow keys to read daily values.
Put RXO on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
RXO arranges full truckload freight shipments across the United States, working as a broker that connects shippers with carriers who have available trailer space. Its best known feature is a digital marketplace that matches these two sides directly, making it easier to move truckload freight without relying solely on traditional manual arrangements.
Beyond matching loads, RXO also brokers a wider set of logistics services. These include managed logistics programs for companies that want to outsource parts of their transportation planning, last-mile delivery for local shipments, and international freight forwarding for goods moving across borders. Together these offerings let RXO serve shippers with varying needs, from single truckload moves to broader supply chain support.
RXO is based in Charlotte, North Carolina. Its shares are listed on the NYSE under the ticker RXO.
RXO’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 37.9, in the Distribution zone, up 1.9 points over five sessions.
Up 1.9 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 51 | +1.1% | +7.8% | ||
| Accumulation | 237 | +1.7% | +2.8% | ||
| Neutral | 356 | −0.1% | −1.2% | ||
| Distribution (current zone) | 32 | +0.3% | +9.1% | ||
| Selling | 6 | Too few readings yet | |||
Average RXO share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
RXO trades 20.2% above Gekko Fair Value of $23.87, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what RXO shares are worth, recalculated every trading day.
$23.87
Gekko Fair Value, Oct 10, 2026
20.2% Overvalued
At the end of Aug 2026 the price was 29.7% above the estimate.
No open-market insider purchases were filed for RXO, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for RXO in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in RXO were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
RXO has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds RXO.
RXO reports on Nov 5, 2026, before the open (24 days away), and beat the EPS estimate in 2 of its last 8 reports.
Nov 5, 2026
Expected before the open, 24 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $0.06 est $0.04 | $1.77B est $1.63B | +3.3% |
| May 7, 2026 | −$0.09 est −$0.09 | $1.43B est $1.34B | +10.9% |
| Feb 6, 2026 | −$0.07 est −$0.04 | $1.47B est $1.49B | −3.2% |
| Nov 6, 2025 | $0.01 est $0.04 | $1.42B est $1.52B | −29.1% |
| Aug 7, 2025 | $0.04 est $0.02 | $1.42B est $1.45B | −5.6% |
| May 7, 2025 | −$0.03 est −$0.02 | $1.43B est $1.55B | +4.9% |
| Feb 5, 2025 | $0.06 est $0.06 | $1.67B est $1.52B | −15.0% |
| Nov 7, 2024 | $0.05 est $0.05 | $1.04B est $975.6M | −6.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for RXO is $27.04, −5.8% from the last close, from 14 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 14 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 8 | Stifel Nicolaus | $33 | +15.0% |
| Oct 7 | Barclays | $28 | −2.4% |
| Oct 7 | Truist Financial | $30 | +4.6% |
| Oct 6 | BMO Capital | $30.25 | +5.4% |
| Oct 6 | TD Cowen | $30.25 | +5.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, RXO averaged −6.0% across the last 3 years, rising in 1 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.7% | 2 of 3 |
| Next 10 trading days | −0.2% | 2 of 3 |
| Next 15 trading days | −0.1% | 2 of 3 |
| Next 20 trading days | −6.0% | 1 of 3 |
| Next 30 trading days | −10.1% | 1 of 3 |
For scale, RXO’s typical 20-trading-day move in either direction is about 8%.
RXO’s market cap is $4.73B and revenue of $6.09B over the last twelve months.
Coverage of RXO this week reads positive: 4 positive, 1 neutral and 2 negative headlines.
RXO’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 21.7% above |
| PLTRPalantir Technologies | Distribution | 22.3% above |
| ORCLOracle | Neutral | 24.3% below |
| PANWPalo Alto Networks | Neutral | 21.6% above |
| CRWDCrowdStrike | Neutral | 23.7% above |
| CRMSalesforce | Neutral | 3.6% below |
A peer links to its own page where one exists.
RXO’s market cap is $4.73B at the Oct 12, 2026 close of $28.69, with 165.0M shares outstanding.
The consensus analyst 12-month price target for RXO is $27.04, −5.8% from the last close. Of the 14 firms that rated the stock in the last 90 days, 4 rate it a buy, 10 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate RXO is overvalued: the Oct 12, 2026 close of $28.69 is 20.2% above Gekko Fair Value of $23.87. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
RXO is expected to report on Nov 5, 2026, before the market opens (24 days away). Analysts expect earnings of $0.08 per share on revenue of $1.82B. RXO beat the earnings estimate in 2 of its last 8 reports, moving 9.8% on average across the report.
RXO’s 52-week high is $29.90 and its 52-week low is $10.43; it closed at $28.69 on Oct 12, 2026, +62.5% over the past year. Over the last five years the shares peaked at $32.82 on Jul 31, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (trend) and 4 as headwinds (gekkoindex, fair value, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.